Chief Secretary Farley Augustine yesterday wished Prime Minister Dr Keith Rowley the best of luck after he announced that he ...

The FDA is expected to decide on treatments for Parkinson disease, PTSD and NF1-associated plexiform neurofibromas, in addition to 2 new vaccines.

Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.

Ahead of the 2025 J.P. Morgan Healthcare Conference scheduled to take place in a few days, Oppenheimer named five potential buyout candidates in biotech on Friday, naming obesity drug developer Viking ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy New Year, biotech ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the ...

The Boston Globe: Last-Minute Health Care Bills Make Needed Reforms Two major bills — one on health care market oversight and another on prescription drug costs — landed on Governor Maura Healey ...

Snake oil, it turns out, motivated the founding of the FDA. The term “snake oil” arose out of a controversy from the late ...

As we enter the new year, all eyes are on the biotech companies awaiting key FDA decisions in January. In 2024, the FDA approved 50 ...

GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of ...